Comparison between Mandhana Industries IPO and Parabolic Drugs IPO.
Mandhana Industries IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Mandhana Industries IPO is up to ₹107.90 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Mandhana Industries IPO is ₹130.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Mandhana Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹130.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹130.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 50 shares | 80 shares |
| Fresh Issue Size | 83,00,000 shares | 2,46,40,965 shares |
| Fresh Issue Size (Amount) | up to ₹107.90 Cr | up to ₹184.81 Cr |
| OFS Issue Size | 0 shares | 20,25,702 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.19 Cr |
| Issue Size Total | 83,00,000 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹107.90 Cr | up to ₹200.00 Cr |
Mandhana Industries IPO opens on Apr 27, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Mandhana Industries IPO and Parabolic Drugs IPO is Apr 29, 2010, and Jun 17, 2010, respectively.
| Mandhana Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Apr 26, 2010 | |
| Issue Open | Apr 27, 2010 | Jun 14, 2010 |
| Issue Close | Apr 29, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 19, 2010 | Jul 01, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mandhana Industries IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Mandhana Industries IPO | Parabolic Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 83.02 | 63.21 | ||||
| Promoter Shareholding (Post-Issue) | 62.21 | 38.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹430.61 Cr. | ₹464.19 Cr. | ||||
| ROE | ||||||
| ROCE | 25.18 | 6.21 | ||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 27.35 | 19.96 |
In the Mandhana Industries IPO Retail Individual Investors (RII) are offered 29,05,000 shares while in Parabolic Drugs IPO retail investors are offered 29,05,000 shares. Qualified Institutional Buyers (QIB) are offered 29,96,150 shares in Mandhana Industries IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Mandhana Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | 11,53,850 shares | |
| Market Maker Reservation | ||
| QIB | 29,96,150 shares | 1,30,83,333 shares |
| NII | 12,45,000 shares | 39,25,000 shares |
| RII | 29,05,000 shares | 91,58,334 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 83,00,000 shares | 2,66,66,667 shares |
Mandhana Industries IPO subscribed 5.44x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Mandhana Industries IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 7.97x | 1.48x |
| NII (times) | 10.52x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.81x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 5.44x | 1.04x |
